Covariate | Estimate* | p Value |
Model 1 | ||
Liver fat at baseline | −0.23 (0.04) | <0.0001 |
Female sex | −0.03 (0.05) | 0.54 |
Age at follow-up | 0.20 (0.16) | 0.20 |
Total adipose tissue at baseline | 0.26 (0.11) | 0.019 |
Model 2 | ||
Liver fat at baseline | −0.25 (0.05) | < 0.0001 |
Female sex | −0.08 (0.05) | 0.12 |
Age at follow-up | 0.04 (0.17) | 0.81 |
Visceral adipose tissue at baseline | 0.23 (0.09) | 0.012 |
Model 3 | ||
Liver fat at baseline | −0.25 (0.04) | < 0.0001 |
Female sex | −0.10 (0.05) | 0.06 |
Age at follow-up | 0.03 (0.16) | 0.84 |
Fitness (VO2,max) at baseline | −0.75 (0.20) | 0.0002 |
Model 4 | ||
Liver fat at baseline | −0.27 (0.04) | < 0.0001 |
Female sex | −0.03 (0.08) | 0.66 |
Age at follow-up | −0.05 (0.19) | 0.78 |
Total adipose tissue at baseline | −0.09 (0.18) | 0.60 |
Visceral adipose tissue at baseline | 0.14 (0.13) | 0.29 |
Fitness (VO2,max) at baseline | −0.70 (0.24) | 0.005 |
*Results are given as mean (SE).